Basic principles of neuroimmunology
- PMID: 35732977
- DOI: 10.1007/s00281-022-00951-7
Basic principles of neuroimmunology
Abstract
The brain is an immune-privileged organ such that immune cell infiltration is highly regulated and better tolerating the introduction of antigen to reduce risk of harmful inflammation. Thus, the composition and the nature of the immune response is fundamentally different in the brain where avoiding immunopathology is prioritized compared to other peripheral organs. While the principle of immune privilege in the central nervous system (CNS) still holds true, the role of the immune system in the CNS has been revisited over the recent years. This redefining of immune privilege in the brain is a result of the recent re-discovery of the extensive CNS meningeal lymphatic system and the identification of resident T cells in the brain, meningeal layers, and its surrounding cerebrospinal fluid (CSF) in both humans and rodents. While neuro-immune interactions have been classically studied in the context of neuroinflammatory disease, recent works have also elucidated unconventional roles of immune-derived cytokines in neurological function, highlighting the many implications and potential of neuro-immune interactions. As a result, the study of neuro-immune interactions is becoming increasingly important in understanding both CNS homeostasis and disease. Here, we review the anatomically distinct immune compartments within the brain, the known mechanisms of leukocyte trafficking and infiltration into the CNS and unique transcriptional and functional characteristics of CNS-resident immune cells.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Mascagni, and C. Sanctius, 1787 Vasorum lymphaticorum corporis humani historia et ichnographia. Ex typographia Pazzini Carli.
-
- Andres KH et al (1987) Nerve fibres and their terminals of the dura mater encephali of the rat. Anat Embryol (Berl) 175(3):289–301 - DOI
Publication types
MeSH terms
Substances
Grants and funding
- U19 AI089992/NH/NIH HHS/United States
- R25 NS079193/NH/NIH HHS/United States
- P01 AI073748/NH/NIH HHS/United States
- U24 AI11867/NH/NIH HHS/United States
- R01 AI22220/NH/NIH HHS/United States
- UM 1HG009390/NH/NIH HHS/United States
- P01 AI039671/NH/NIH HHS/United States
- P50 CA121974/NH/NIH HHS/United States
- R01 CA227473/NH/NIH HHS/United States
- K08 AI128745/NH/NIH HHS/United States
- R01 AI162645/NH/NIH HHS/United States
- 5T32 AI 007019-46/NH/NIH HHS/United States
- CA 1061- A-18/MSS_/Multiple Sclerosis Society/United Kingdom
- RG-1802-30153/MSS_/Multiple Sclerosis Society/United Kingdom
LinkOut - more resources
Full Text Sources
Research Materials